Clinical Trials Browser

OTHER × Male Urogenital Diseases × Clear all

Penile Neoplasms, Urogenital Neoplasms, Urologic Neoplasms, Male Urogenital Diseases

NCT06676527 2025-12-05

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

Urogenital Diseases, Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Female Urogenital Diseases, Male Urogenital Diseases

NCT06659926 2025-07-08

The Radium-select Study

Phase NA Recruiting

60 enrolled

Male Urogenital Diseases

NCT00946881 2024-02-07

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Phase 1/2 Completed

30 enrolled 12 charts

Genitourinary

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT03721029 2023-03-02

Intraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy

Phase NA Completed

100 enrolled

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence, Male Urogenital Diseases

NCT04225299 2020-11-13

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

Phase 3 Withdrawn

Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT01443026 2019-11-19

The Effects of Lycopene on High Risk Prostatic Tissue

Phase 2 Completed

66 enrolled 8 charts

Genitourinary

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia, Male Urogenital Diseases

NCT01310894 2019-07-11

PCM301

Phase 3 Completed

413 enrolled

Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Phase 2 Completed

16 enrolled

Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Phase 2 Completed

48 enrolled

Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00707356 2016-04-19

Study of WST11 in Patients With Localized Prostate Cancer

Phase 2 Completed

42 enrolled

Genitourinary

Genital Diseases, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

NCT00975429 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

Phase 2 Completed

86 enrolled

Genitourinary

Carcinoma, Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Male Urogenital Diseases

Clinical Trials

PRIAM

Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma

The Radium-select Study

Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer

Intraoperative Nerve Monitoring During Robotic-assisted Radical Prostatectomy

Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer

The Effects of Lycopene on High Risk Prostatic Tissue

PCM301

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Study of WST11 in Patients With Localized Prostate Cancer

Study Using WST11 in Patients With Localized Prostate Cancer